 BOSTON, MA ACCESSWIRE July 28, 2022 Pieris Pharmaceuticals, Inc. NASDAQ:PIRS , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer and other indications, today announced that it will host a second quarter 2022 investor call on Thursday, August 4, 2022 at 8:00 AM EDT to discuss financial results and provide a corporate update. To access the call, participants may dial 800 285-6670 Toll Free US Canada or 713 481-1320 International at least five minutes prior to the start of the call. 